123 related articles for article (PubMed ID: 8738204)
1. Bacterial contamination of autologous bone marrow during processing.
Smith D; Bradley SJ; Scott GM
J Hosp Infect; 1996 May; 33(1):71-6. PubMed ID: 8738204
[TBL] [Abstract][Full Text] [Related]
2. Detection of bacterial contamination in bone marrow graft.
D'Antonio D; Iacone A; Fioritoni G; Dragani A; Betti S; Quaglietta AM; Di Gianfilippo R; Accorsi P; Recchia A; Di Girolamo A
Haematologica; 1991 Mar; 76 Suppl 1():44-5. PubMed ID: 1864553
[TBL] [Abstract][Full Text] [Related]
3. Bacterial contamination of autologous bone marrow: reinfusion of culture-positive grafts does not result in clinical sequelae during the posttransplantation course.
Schwella N; Rick O; Heuft HG; Miksits K; Zimmermann R; Zingsem J; Eckstein R; Huhn D
Vox Sang; 1998; 74(2):88-94. PubMed ID: 9501406
[TBL] [Abstract][Full Text] [Related]
4. Contamination during in vitro processing of bone marrow for transplantation: clinical significance.
Lazarus HM; Magalhaes-Silverman M; Fox RM; Creger RJ; Jacobs M
Bone Marrow Transplant; 1991 Mar; 7(3):241-6. PubMed ID: 2059759
[TBL] [Abstract][Full Text] [Related]
5. Contamination of bone marrow products with an actinomycete resembling Microbacterium species and reinfusion into autologous stem cell and bone marrow transplant recipients.
Hirji Z; Saragosa R; Dedier H; Crump M; Franke N; Burrows L; Jamieson F; Brown S; Gardam MA
Clin Infect Dis; 2003 May; 36(10):e115-21. PubMed ID: 12746790
[TBL] [Abstract][Full Text] [Related]
6. Bacterial contamination of bone marrow grafts intended for autologous and allogeneic bone marrow transplantation. Incidence and clinical significance.
Rowley SD; Davis J; Dick J; Braine HG; Charache P; Saral R; Sensenbrenner LL; Santos GW
Transfusion; 1988; 28(2):109-12. PubMed ID: 3281332
[TBL] [Abstract][Full Text] [Related]
7. Microbial contamination of BM products before and after processing: a report of incidence and immediate adverse events in 257 grafts.
Vanneaux V; Foïs E; Robin M; Rea D; de Latour RP; Biscay N; Chantre E; Robert I; Wargnier A; Traineau R; Benbunan M; Marolleau J; Socié G; Larghero J
Cytotherapy; 2007; 9(5):508-13. PubMed ID: 17786612
[TBL] [Abstract][Full Text] [Related]
8. Bacterial contamination of autologous bone marrow during processing.
Wilcox MH
J Hosp Infect; 1996 Sep; 34(1):77-8. PubMed ID: 8880555
[No Abstract] [Full Text] [Related]
9. Incidence of bacterial contamination of bone marrow grafts.
Schepers KG; Davis JM; Rowley SD
Prog Clin Biol Res; 1992; 377():379-84. PubMed ID: 1438434
[No Abstract] [Full Text] [Related]
10. Quality control of bacterial contamination in autologous peripheral blood stem cells for transplantation.
Larrea L; de la Rubia J; Soler MA; Ribas P; Fernández JM; Picón I; García-Boyero R; García-Bellés C; Roig R
Haematologica; 2004 Oct; 89(10):1232-7. PubMed ID: 15477209
[TBL] [Abstract][Full Text] [Related]
11. Bacterial contamination of autologous bone marrow during processing.
Farrington M; Matthews I; Jestice HK; Scott MA; Marcus RE; Hunt C; Foreman J
J Hosp Infect; 1996 Nov; 34(3):230-3. PubMed ID: 8923280
[No Abstract] [Full Text] [Related]
12. Transporting bone marrow for in vitro purging before autologous reinfusion.
Janssen WE; Gee AP; Graham-Pole JR; Lee C; Luzins J; Spencer C; Worthington-White DA; Pick T; Koch P; Gross S
Prog Clin Biol Res; 1990; 333():541-9. PubMed ID: 2309000
[TBL] [Abstract][Full Text] [Related]
13. Microbial contamination of harvested bone marrow and peripheral blood.
Prince HM; Page SR; Keating A; Saragosa RF; Vukovic NM; Imrie KR; Crump M; Stewart AK
Bone Marrow Transplant; 1995 Jan; 15(1):87-91. PubMed ID: 7742761
[TBL] [Abstract][Full Text] [Related]
14. Influence of harvest bacterial contamination on autologous peripheral blood progenitor cells post-transplant.
Majado MJ; García-Hernández A; Morales A; González C; Martínez-Sánchez V; Menasalvas A; Rosique P; Rubio A; Sanz-Imedio E
Bone Marrow Transplant; 2007 Jan; 39(2):121-5. PubMed ID: 17173054
[TBL] [Abstract][Full Text] [Related]
15. Adverse reactions in patients transfused with cryopreserved marrow.
Stroncek DF; Fautsch SK; Lasky LC; Hurd DD; Ramsay NK; McCullough J
Transfusion; 1991; 31(6):521-6. PubMed ID: 1853447
[TBL] [Abstract][Full Text] [Related]
16. Surveillance of nosocomial infections in adult recipients of allogeneic and autologous bone marrow and peripheral blood stem-cell transplantation.
Dettenkofer M; Ebner W; Bertz H; Babikir R; Finke J; Frank U; Rüden H; Daschner FD
Bone Marrow Transplant; 2003 May; 31(9):795-801. PubMed ID: 12732887
[TBL] [Abstract][Full Text] [Related]
17. Norfloxacin prophylaxis for neutropenic patients undergoing bone marrow transplantation.
Menichetti F; Felicini R; Bucaneve G; Aversa F; Greco M; Pasquarella C; Moretti MV; Del Favero A; Martelli MF
Bone Marrow Transplant; 1989 Sep; 4(5):489-92. PubMed ID: 2790326
[TBL] [Abstract][Full Text] [Related]
18. Germ monitoring of patients, staff and environment in reverse isolation.
Hoffmann FA; Mittelstedt B; Kubel M; Helbig W
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):577-80. PubMed ID: 2480311
[TBL] [Abstract][Full Text] [Related]
19. Microbial contamination of hematopoietic progenitor cell grafts-incidence, clinical outcome, and cost-effectiveness: an analysis of 735 grafts.
Kamble R; Pant S; Selby GB; Kharfan-Dabaja MA; Sethi S; Kratochvil K; Kohrt N; Ozer H
Transfusion; 2005 Jun; 45(6):874-8. PubMed ID: 15934984
[TBL] [Abstract][Full Text] [Related]
20. Sources and sequelae of bacterial contamination of hematopoietic stem cell components: implications for the safety of hematotherapy and graft engineering.
Webb IJ; Coral FS; Andersen JW; Elias AD; Finberg RW; Nadler LM; Ritz J; Anderson KC
Transfusion; 1996 Sep; 36(9):782-8. PubMed ID: 8823450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
